>السوق العالمية لتسلسل الإكسوم الكامل، حسب المكون (تسلسل الجيل الثاني والتسلسل الجيل الثالث)، المنتج والخدمة (الأنظمة والمجموعات والخدمات)، التطبيق (اكتشاف وتطوير الأدوية، البحوث الزراعية والحيوانية، التشخيص، الطب الشخصي، وغيرها)، المستخدم النهائي (شركات الأدوية والتكنولوجيا الحيوية، المعاهد الأكاديمية والبحثية، المستشفيات والعيادات، المختبرات السريرية، وغيرها)، قناة التوزيع (التجارة المباشرة، مبيعات التجزئة، وغيرها)، اتجاهات الصناعة والتوقعات حتى عام 2029.
تحليل السوق والرؤى
من المتوقع أن يكتسب سوق تسلسل الإكسوم العالمي نموًا في السوق في الفترة المتوقعة من 2022 إلى 2029. تحلل شركة Data Bridge Market Research أن السوق ينمو بمعدل نمو سنوي مركب بنسبة 19.0٪ في الفترة المتوقعة من 2022 إلى 2029. الزيادة في الإنفاق على الرعاية الصحية والتمويل هي المحركات الرئيسية التي دفعت الطلب على السوق في الفترة المتوقعة.
ومع ذلك، فإن الآثار الجانبية المرتبطة بعلاجات تسلسل الإكسوم الكامل قد تعيق النمو المستقبلي لسوق تسلسل الإكسوم الكامل. إن تبني التحالفات الاستراتيجية مثل الشراكات والاستحواذات من قبل اللاعبين الرئيسيين في السوق بمثابة فرصة لنمو سوق تسلسل الإكسوم الكامل.
|
تقرير القياس |
تفاصيل |
|
فترة التنبؤ |
2022 إلى 2029 |
|
سنة الأساس |
2021 |
|
سنوات تاريخية |
2020 |
|
وحدات كمية |
الإيرادات بالملايين من الدولارات الأمريكية، التسعير بالدولار الأمريكي |
|
القطاعات المغطاة |
حسب المكون (تسلسل الجيل الثاني وتسلسل الجيل الثالث)، المنتج والخدمة (الأنظمة والمجموعات والخدمات)، التطبيق (اكتشاف وتطوير الأدوية، البحوث الزراعية والحيوانية، التشخيص، الطب الشخصي، وغيرها)، المستخدم النهائي (شركات الأدوية والتكنولوجيا الحيوية، المعاهد الأكاديمية والبحثية، المستشفيات والعيادات، المختبرات السريرية، وغيرها)، قناة التوزيع (التجارة المباشرة، مبيعات التجزئة، وغيرها) |
|
الدول المغطاة |
الولايات المتحدة الأمريكية، كندا، المكسيك، ألمانيا، فرنسا، إيطاليا، المملكة المتحدة، إسبانيا، هولندا، روسيا، سويسرا، تركيا، بلجيكا، بقية أوروبا، اليابان، الصين، الهند، كوريا الجنوبية، أستراليا، سنغافورة، ماليزيا، تايلاند، إندونيسيا، الفلبين، فيتنام، بقية دول آسيا والمحيط الهادئ، البرازيل، الأرجنتين، بقية دول أمريكا الجنوبية، المملكة العربية السعودية، جنوب أفريقيا، الإمارات العربية المتحدة، إسرائيل، مصر، بقية دول الشرق الأوسط وأفريقيا |
|
الجهات الفاعلة في السوق المشمولة |
Thermo Fisher Scientific Inc.، QIAGEN، Illumina، Inc.، Beckman Coulter، Inc.، Eurofins Scientific، BIONEER CORPORATION، ExoDx (جزء من Bio-Techne)، FOUNDATION MEDICINE، INC. (شركة تابعة لشركة F. Hoffmann-La Roche Ltd)، GeneFirst Limited، CeGaT GmbH، Meridian، Merck KGaA، SOPHiA GENETICS، Azenta US Inc.، CD Genomics، Twist Bioscience، PerkinElmer Genomics (شركة تابعة لشركة PerkinElmer Inc.)، GeneDx، LLC، Psomagen، Integrated DNA Technologies، Inc.، وغيرها. |
تعريف سوق تسلسل الإكسوم الكامل
إن تسلسل الإكسوم الكامل هو تقنية جينومية لتسلسل جميع مناطق ترميز البروتين في الجينات الموجودة في الجينوم. ويتوفر تسلسل الإكسوم الكامل للمرضى الذين يبحثون عن تشخيص موحد لحالات طبية متعددة. وهي عملية معملية تُستخدم لتحديد تسلسل النوكليوتيدات في المقام الأول للمناطق الإكسونية (أو ترميز البروتين) في جينوم الفرد والتسلسلات ذات الصلة، والتي تمثل ما يقرب من 1% من تسلسل الحمض النووي الكامل، والذي يُسمى أيضًا WES. إن تسلسل الإكسوم الكامل هو طريقة تسلسل الإكسوم الكامل المستخدمة على نطاق واسع والتي تتضمن تسلسل مناطق ترميز البروتين في الجينوم. يمثل الإكسوم البشري أقل من 2% من الجينوم، ولكنه يحتوي على حوالي 85% من المتغيرات المعروفة المرتبطة بالأمراض، مما يجعل هذه الطريقة بديلاً فعالاً من حيث التكلفة لتسلسل الجينوم الكامل.
يمكن لتسلسل الإكسوم باستخدام إثراء الإكسوم أن يكشف بكفاءة عن المتغيرات المشفرة عبر مجموعة واسعة من التطبيقات، بما في ذلك علم الوراثة السكانية والأمراض الوراثية ودراسات السرطان. ويعزى نمو سوق تسلسل الإكسوم العالمي بالكامل إلى انخفاض الوقت والتكلفة اللازمة للتسلسل. ومع تطور التقنيات الجديدة وعلاج السرطان، فإن سوق تسلسل الإكسوم بالكامل في علم الأورام السريري لديه إمكانات هائلة في السنوات القادمة.
ديناميكيات سوق تسلسل الإكسوم الكامل
السائقين
- زيادة في اعتماد تسلسل الجيل التالي
مع استمرار علم الأدوية الذي يركز على الجينوم في لعب دور أكبر في علاج العديد من الأمراض المزمنة وخاصة السرطان، يتطور تسلسل الجيل التالي (NGS) كأداة قوية لتوفير نظرة أعمق وأكثر دقة حول الأسس الجزيئية للأورام الفردية والمستقبلات المحددة.
تقدم تقنية الجيل التالي من الجينوم مزايا في الدقة والحساسية والسرعة مقارنة بالطرق التقليدية التي لديها القدرة على إحداث تأثير كبير في مجال علم الأورام. ولأن تقنية الجيل التالي من الجينوم قادرة على تقييم جينات متعددة في اختبار واحد، فإن الحاجة إلى طلب اختبارات متعددة لتحديد الطفرة المسببة يتم التخلص منها.
- الاستخدام المتزايد لأساليب التسلسل المستهدفة
مع استمرار علم الأدوية الذي يركز على الجينوم في لعب دور أكبر في علاج العديد من الأمراض المزمنة وخاصة السرطان، يتطور تسلسل الجيل التالي (NGS) كأداة قوية لتوفير نظرة أعمق وأكثر دقة حول الأسس الجزيئية للأورام الفردية والمستقبلات المحددة.
تقدم تقنية الجيل التالي من الجينوم مزايا في الدقة والحساسية والسرعة مقارنة بالطرق التقليدية التي لديها القدرة على إحداث تأثير كبير في مجال علم الأورام. ولأن تقنية الجيل التالي من الجينوم قادرة على تقييم جينات متعددة في اختبار واحد، فإن الحاجة إلى طلب اختبارات متعددة لتحديد الطفرة المسببة يتم التخلص منها.
ضبط النفس
-
تغطية أقل شمولاً للإكسونات
لا يتم التقاط جميع الإكسونات بشكل شامل. قد لا يتم تضمين الإكسون المهم في التعليقات التوضيحية القياسية الحالية للجينوم البشري؛ ومن الصعب للغاية تغطية 100% من الإكسوم باستخدام تقنية WES الحالية. وبالتالي، فإن المتغيرات المسببة للأمراض في هذه الإكسونات "المفقودة" لا يتم اكتشافها.
تتمتع تقنية WES بحساسية منخفضة للتغيرات البنيوية، وبالتالي يكون الكشف عنها محدودًا. ومع ذلك، يمكن اكتشاف بعض المتغيرات في عدد النسخ، بما في ذلك عمليات الحذف والإضافة، بواسطة تقنية WES، إلا أن القيد الفني يعني أن البعض الآخر قد يتم تجاهله
فرصة
-
المبادرات الاستراتيجية التي يتخذها اللاعب الرئيسي في السوق
يتزايد الطلب على تسلسل الإكسوم الكامل في السوق بسبب زيادة حالات الإصابة بالأمراض الوراثية إلى جانب زيادة عدد السكان المسنين في جميع أنحاء المنطقة. وبالتالي، نفذ كبار اللاعبين في السوق استراتيجية التعاون مع لاعبين آخرين في السوق بهدف تحسين العمليات التجارية والربحية.
تحدي
- القضايا الأخلاقية والقانونية المتعلقة بتسلسل الإكسوم الكامل
إن التقدم السريع في تقنيات الجينوم عالية الإنتاجية وتسلسل الجيل التالي يجعل البحث الجينومي الطبي أكثر سهولة في الوصول وبأسعار معقولة، بما في ذلك تسلسل الجينوم الكامل والإكسومات للمرضى والمراقبين من أجل توضيح العوامل الوراثية الكامنة وراء المرض. لقد أدى تقدم تقنيات الجينوم عالية الإنتاجية وطرق تسلسل الجيل التالي في السنوات الأخيرة إلى تغيير نطاق الدراسات الجينومية البشرية. وقد جعلت هذه التطورات من الممكن إجراء دراسات تسلسل الإكسوم الكامل بشكل روتيني.
وبسبب الطبيعة التعاونية واسعة النطاق للدراسات، أصبحت القضايا الأخلاقية والقانونية محل قلق متزايد ولها آثار مهمة في أفريقيا. وتحظى الشعوب الأفريقية باهتمام فريد من نوعه، وذلك على الرغم من امتلاكها لأعلى مستويات التنوع الجيني، وعيشها في مجموعة واسعة من البيئات الثقافية والبيئية، فضلاً عن معاناتها من عبء مرتفع من الأمراض التي يمكن دراستها باستخدام مناهج الجينوم، إلا أنها تواجه قضايا قانونية في مجال المياه النظيفة.
تأثير ما بعد كوفيد-19 على سوق تسلسل الإكسوم الكامل
أدى انتشار فيروس كورونا المستجد إلى زيادة كبيرة في الطلب على المستلزمات الطبية من قبل كل من المتخصصين في الرعاية الصحية وعامة الناس كإجراءات احترازية. وتتاح الفرصة لمصنعي هذه العناصر للاستفادة من الطلب المتزايد على المستلزمات الطبية من خلال ضمان إمداد ثابت من معدات الحماية الشخصية في السوق. ومن المتوقع أن يكون لفيروس كورونا المستجد تأثير كبير على سوق تسلسل الإكسوم بأكمله.
التطورات الأخيرة
- في مايو 2022، أبرمت شركة Thermo Fisher Scientific، الرائدة عالميًا في خدمة العلوم، وبرنامج قطر جينوم (QGP)، عضو مؤسسة قطر، شراكة بهدف تسريع البحث الجينومي والتطبيقات السريرية لعلم الجينوم التنبؤي في قطر كخطوة نحو توسيع فوائد الطب الدقيق بين السكان العرب على مستوى العالم. وقد ساعد هذا الشركة على توسيع حضورها.
- في مارس 2022، قامت العديد من شركات ومختبرات الجينوم الرائدة، بما في ذلك Illumina وFulgent Genetics وInvitae وGeneDx وPerkinElmer Genomics، بتشكيل تحالف اختبار CardioGenomic (CGTA)، وهي مجموعة تعاونية تهدف إلى زيادة الوعي بالاختبارات الجينية واستخدامها في أمراض القلب. تسعى CGTA إلى تثقيف مقدمي الرعاية الصحية وأصحاب المصلحة الآخرين حول قيمة مثل هذه الاختبارات لضمان الالتزام بالمبادئ التوجيهية الحالية من الجمعيات الطبية المهنية، ولإبلاغ الإدارة الطبية والاختبار المتتالي، وتحسين النتائج السريرية. وقد ساعد هذا الشركة على الالتزام بالمبادئ التوجيهية.
تجزئة سوق التسلسل الكامل للإكسوم العالمي
يتم تقسيم سوق تسلسل الإكسوم العالمي بالكامل على أساس المكون والمنتج والخدمة والتطبيق والمستخدم النهائي وقناة التوزيع. يساعدك النمو بين القطاعات على تحليل جيوب النمو والاستراتيجيات المتخصصة للتعامل مع السوق وتحديد مجالات التطبيق الأساسية لديك والاختلاف في أسواقك المستهدفة.
عنصر
- تسلسل الجيل الثاني
- تسلسل الجيل الثالث
على أساس المكون، يتم تقسيم سوق تسلسل الإكسوم العالمي بأكمله إلى تسلسل الجيل الثاني وتسلسل الجيل الثالث.
المنتج والخدمات
- الأنظمة
- مجموعات
- خدمات
على أساس المنتج والخدمة، يتم تقسيم سوق تسلسل الإكسوم العالمي بأكمله إلى أنظمة ومجموعات وخدمات.
طلب
- التشخيص
- اكتشاف وتطوير الأدوية
- الطب الشخصي
- البحوث الزراعية والحيوانية
- آحرون
على أساس التطبيق، يتم تقسيم سوق تسلسل الإكسوم العالمي بأكمله إلى اكتشاف وتطوير الأدوية، والبحوث الزراعية والحيوانية، والتشخيص، والطب الشخصي وغيرها.
المستخدم النهائي
- المستشفيات والعيادات
- شركات الأدوية والتكنولوجيا الحيوية
- المؤسسات الأكاديمية والبحثية
- المختبرات الطبية
- آحرون
على أساس المستخدم النهائي، يتم تقسيم سوق تسلسل الإكسوم الكامل العالمي إلى شركات الأدوية والتكنولوجيا الحيوية والمعاهد الأكاديمية والبحثية والمستشفيات والعيادات والمختبرات السريرية وغيرها.
قناة التوزيع
- التجارة المباشرة
- مبيعات التجزئة
- آحرون
على أساس قناة التوزيع، يتم تقسيم سوق تسلسل الإكسوم العالمي بأكمله إلى التجارة المباشرة ومبيعات التجزئة وغيرها.
تحليل/رؤى إقليمية لسوق تسلسل الإكسوم الكامل
يتم تحليل سوق تسلسل الإكسوم بأكمله وتوفير معلومات حجم السوق حسب المكون والمنتج والخدمة والتطبيق والمستخدم النهائي وقناة التوزيع.
الدول التي يغطيها تقرير سوق تسلسل الإكسوم الكامل هي الولايات المتحدة وكندا والمكسيك وألمانيا وفرنسا وإيطاليا والمملكة المتحدة وإسبانيا وهولندا وروسيا وسويسرا وتركيا وبلجيكا وبقية أوروبا واليابان والصين والهند وكوريا الجنوبية وأستراليا وسنغافورة وماليزيا وتايلاند وإندونيسيا والفلبين وفيتنام وبقية دول آسيا والمحيط الهادئ والبرازيل والأرجنتين وبقية دول أمريكا الجنوبية والمملكة العربية السعودية وجنوب إفريقيا والإمارات العربية المتحدة وإسرائيل ومصر وبقية دول الشرق الأوسط وأفريقيا.
تسيطر أمريكا الشمالية على السوق بسبب وجود لاعبين رئيسيين في السوق إلى جانب أكبر سوق استهلاكية ذات ناتج محلي إجمالي مرتفع. ومن المتوقع أن تنمو الولايات المتحدة بسبب ارتفاع التقدم التكنولوجي.
كما يوفر قسم الدولة في التقرير عوامل التأثير الفردية على السوق والتغييرات في التنظيم في السوق محليًا والتي تؤثر على الاتجاهات الحالية والمستقبلية للسوق. تعد نقاط البيانات مثل المبيعات الجديدة ومبيعات الاستبدال والتركيبة السكانية للدولة والقوانين التنظيمية ورسوم الاستيراد والتصدير من بين المؤشرات الرئيسية المستخدمة للتنبؤ بسيناريو السوق للدول الفردية. كما يتم النظر في وجود وتوافر العلامات التجارية العالمية والتحديات التي تواجهها بسبب المنافسة الكبيرة أو النادرة من العلامات التجارية المحلية والمحلية وتأثير قنوات المبيعات أثناء تقديم تحليل توقعات لبيانات الدولة.
يوفر لك سوق تسلسل الإكسوم الكامل أيضًا تحليلًا تفصيليًا للسوق لكل نمو في صناعة الرعاية الصحية في كل دولة. علاوة على ذلك، يوفر معلومات مفصلة حول خدمات الرعاية الصحية والعلاجات، وتأثير السيناريوهات التنظيمية، والمعايير السائدة فيما يتعلق بسوق تسلسل الإكسوم الكامل.
تحليل المشهد التنافسي وحصة سوق التسلسل الكامل للإكسوم
يوفر المشهد التنافسي العالمي لسوق تسلسل الإكسوم الكامل تفاصيل حسب المنافس. تتضمن التفاصيل نظرة عامة على الشركة، والمالية للشركة، والإيرادات المتولدة، وإمكانات السوق، والاستثمار في البحث والتطوير، ومبادرات السوق الجديدة، ومواقع الإنتاج والمرافق، ونقاط القوة والضعف في الشركة، وإطلاق المنتج، وخطوط أنابيب تجارب المنتجات، وموافقات المنتج، وبراءات الاختراع، وعرض المنتج ونفسه، وهيمنة التطبيق، ومنحنى شريان الحياة التكنولوجي. ترتبط نقاط البيانات المذكورة أعلاه فقط بتركيز الشركة فيما يتعلق بسوق تسلسل الإكسوم الكامل.
الشركات الكبرى التي تتعامل في سوق تسلسل الإكسوم بأكمله هي Thermo Fisher Scientific Inc. و QIAGEN و Illumina، Inc. و Beckman Coulter، Inc. و Eurofins Scientific و BIONEER CORPORATION و ExoDx (جزء من Bio-Techne) و FOUNDATION MEDICINE، INC. (شركة تابعة لشركة F. Hoffmann-La Roche Ltd) و GeneFirst Limited و CeGaT GmbH و Meridian و Merck KGaA و SOPHiA GENETICS و Azenta US Inc. و CD Genomics و Twist Bioscience و PerkinElmer Genomics (شركة تابعة لشركة PerkinElmer Inc.) و GeneDx، LLC و Psomagen و Integrated DNA Technologies، Inc. وغيرها.
منهجية البحث
يتم جمع البيانات وتحليل سنة الأساس باستخدام وحدات جمع البيانات ذات أحجام العينات الكبيرة. يتم تحليل بيانات السوق وتقديرها باستخدام نماذج إحصائية ومتماسكة للسوق. بالإضافة إلى ذلك، يعد تحليل حصة السوق وتحليل الاتجاهات الرئيسية من عوامل النجاح الرئيسية في تقرير السوق. منهجية البحث الرئيسية التي يستخدمها فريق بحث DBMR هي مثلث البيانات والتي تتضمن استخراج البيانات وتحليل تأثير متغيرات البيانات على السوق والتحقق الأساسي (خبير الصناعة). وبصرف النظر عن هذا، تتضمن نماذج البيانات شبكة وضع البائعين وتحليل الخط الزمني للسوق ونظرة عامة على السوق والدليل وشبكة وضع الشركة وتحليل حصة الشركة في السوق ومعايير القياس وتحليل آسيا والمحيط الهادئ مقابل التحليل الإقليمي وحصة البائعين. يرجى طلب مكالمة محلل في حالة وجود استفسار آخر.
SKU-
احصل على إمكانية الوصول عبر الإنترنت إلى التقرير الخاص بأول سحابة استخبارات سوقية في العالم
- لوحة معلومات تحليل البيانات التفاعلية
- لوحة معلومات تحليل الشركة للفرص ذات إمكانات النمو العالية
- إمكانية وصول محلل الأبحاث للتخصيص والاستعلامات
- تحليل المنافسين باستخدام لوحة معلومات تفاعلية
- آخر الأخبار والتحديثات وتحليل الاتجاهات
- استغل قوة تحليل المعايير لتتبع المنافسين بشكل شامل
Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL WHOLE EXOME SEQUENCING (WES) MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET APPLICATION COVERAGE GRID
2.8 PRODUCT TYPE LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHT
4.1 PORTER’S FIVE FORCES
4.2 PESTEL ANALYSIS
4.3 INDUSTRIAL INSIGHTS:
4.4 CONCLUSION
5 GLOBAL WHOLE EXOME SEQUENCING MARKET: REGULATIONS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 GROWING USAGE OF TARGETED SEQUENCING METHODS
6.1.2 INCREASE IN THE ADOPTION OF NEXT GENERATION SEQUENCING
6.1.3 INCREASING DIAGNOSTICS APPLICATIONS OF WHOLE EXOME SEQUENCING
6.1.4 INCREASE TREND TOWARD PERSONALIZED MEDICATION
6.2 RESTRAINTS
6.2.1 LESS COMPREHENSIVE COVERAGE OF EXONS
6.2.2 CYBER SECURITY CONCERNS IN GENOMICS
6.3 OPPORTUNITIES
6.3.1 STRATEGIC INITIATIVES BY THE KEY MARKET PLAYER
6.3.2 INCREASING PRODUCT LAUNCHES IN RECENT YEARS
6.4 CHALLENGES
6.4.1 LACK OF SKILLED PROFESSIONALS
6.4.2 ETHICAL AND LEGAL ISSUES RELATED TO WHOLE EXOME SEQUENCING
7 GLOBAL WHOLE EXOME SEQUENCING MARKET, BY COMPONENT
7.1 OVERVIEW
7.2 SECOND-GENERATION SEQUENCING
7.2.1 SEQUENCING BY SYNTHESIS (SBS)
7.2.2 SEQUENCING BY HYBRIDIZATION (SBH) AND SEQUENCING BY LIGATION (SBL)
7.3 THIRD-GENERATION SEQUENCING
8 GLOBAL WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE
8.1 OVERVIEW
8.2 SYSTEMS
8.2.1 HISEQ SERIES
8.2.1.1 HISEQ 2500
8.2.1.2 HISEQ 1500
8.2.2 MISEQ SERIES
8.2.3 ION TORRENT PLATFORMS
8.2.3.1 ION PROTON
8.2.3.2 ION PGM
8.2.4 OTHERS
8.3 KITS
8.3.1 DNA FRAGMENTATION, END REPAIR, A-TAILING, AND SIZE SELECTION KITS
8.3.2 LIBRARY PREPARATION KITS
8.3.3 TARGET ENRICHMENT KITS
8.3.4 OTHERS
8.4 SERVICES
8.4.1 SEQUENCING SERVICES
8.4.2 DATA ANALYSIS (BIOINFORMATICS) SERVICES
8.4.3 OTHERS
9 GLOBAL WHOLE EXOME SEQUENCING MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 DRUG DISCOVERY AND DEVELOPMENT
9.3 AGRICULTURE & ANIMAL RESEARCH
9.4 DIAGNOSTICS
9.5 PERSONALIZED MEDICINE
9.6 OTHERS
10 GLOBAL WHOLE EXOME SEQUENCING MARKET, BY END USER
10.1 OVERVIEW
10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
10.3 ACADEMIC & RESEARCH INSTITUTES
10.4 HOSPITALS AND CLINICS
10.5 CLINICAL LABORATORIES
10.6 OTHERS
11 GLOBAL WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 DIRECT TRADE
11.3 RETAIL SALES
11.4 OTHERS
12 GLOBAL WHOLE EXOME SEQUENCING MARKET, BY REGION
12.1 OVERVIEW
12.2 NORTH AMERICA
12.2.1 U.S.
12.2.2 CANADA
12.2.3 MEXICO
12.3 EUROPE
12.3.1 GERMANY
12.3.2 FRANCE
12.3.3 U.K.
12.3.4 RUSSIA
12.3.5 ITALY
12.3.6 SPAIN
12.3.7 TURKEY
12.3.8 NETHERLANDS
12.3.9 SWITZERLAND
12.3.10 BELGIUM
12.3.11 REST OF EUROPE
12.4 ASIA-PACIFIC
12.4.1 CHINA
12.4.2 JAPAN
12.4.3 INDIA
12.4.4 SOUTH KOREA
12.4.5 AUSTRALIA
12.4.6 SINGAPORE
12.4.7 THAILAND
12.4.8 INDONESIA
12.4.9 PHILIPPINES
12.4.10 MALAYSIA
12.4.11 VIETNAM
12.4.12 REST OF ASIA-PACIFIC
12.5 SOUTH AMERICA
12.5.1 BRAZIL
12.5.2 ARGENTINA
12.5.3 REST OF SOUTH AMERICA
12.6 MIDDLE EAST AND AFRICA
12.6.1 SOUTH AFRICA
12.6.2 SAUDI ARABIA
12.6.3 U.A.E
12.6.4 ISRAEL
12.6.5 EGYPT
12.6.6 REST OF MIDDLE EAST AND AFRICA
13 GLOBAL WHOLE EXOME SEQUENCING MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: GLOBAL
13.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
13.3 COMPANY SHARE ANALYSIS: EUROPE
13.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
14 COMPANY PROFILE
14.1 PERKINELMER GENOMICS (A SUBSIDIARY OF PERKINELMER INC.)
14.1.1 COMPANY SNAPSHOT
14.1.2 REVENUE ANALYSIS
14.1.3 COM PANY SHARE ANALYSIS
14.1.4 PRODUCT PORTFOLIO
14.1.5 RECENT DEVELOPMENTS
14.2 MERCK KGAA
14.2.1 COMPANY SNAPSHOT
14.2.2 REVENUE ANALYSIS
14.2.3 COM PANY SHARE ANALYSIS
14.2.4 PRODUCT PORTFOLIO
14.2.5 RECENT DEVELOPMENTS
14.3 EXODX (A PART OF BIO-TECHNE)
14.3.1 COMPANY SNAPSHOT
14.3.2 REVENUE ANALYSIS
14.3.3 COM PANY SHARE ANALYSIS
14.3.4 PRODUCT PORTFOLIO
14.3.5 RECENT DEVELOPMENTS
14.4 THERMO FISHER SCIENTIFIC INC.
14.4.1 COMPANY SNAPSHOT
14.4.2 REVENUE ANALYSIS
14.4.3 COM PANY SHARE ANALYSIS
14.4.4 PRODUCT PORTFOLIO
14.4.5 RECENT DEVELOPMENTS
14.5 FOUNDATION MEDICINE, INC. (A SUBSIDIARY OF F. HOFFMANN-LA ROCHE LTD)
14.5.1 COMPANY SNAPSHOT
14.5.2 REVENUE ANALYSIS
14.5.3 COM PANY SHARE ANALYSIS
14.5.4 PRODUCT PORTFOLIO
14.5.5 RECENT DEVELOPMENTS
14.6 AZENTA US, INC.
14.6.1 COMPANY SNAPSHOT
14.6.2 PRODUCT PORTFOLIO
14.6.3 RECENT DEVELOPMENTS
14.7 BECKMAN COULTER, INC
14.7.1 COMPANY SNAPSHOT
14.7.2 REVENUE ANALYSIS
14.7.3 PRODUCT PORTFOLIO
14.7.4 RECENT DEVELOPMENTS
14.8 BIONEER CORPORATION
14.8.1 COMPANY SNAPSHOT
14.8.2 REVENUE ANALYSIS
14.8.3 PRODUCT PORTFOLIO
14.8.4 RECENT DEVELOPMENTS
14.9 CD GENOMICS
14.9.1 COMPANY SNAPSHOT
14.9.2 PRODUCT PORTFOLIO
14.9.3 RECENT DEVELOPMENTS
14.1 CEGAT GMBH
14.10.1 COMPANY SNAPSHOT
14.10.2 PRODUCT PORTFOLIO
14.10.3 RECENT DEVELOPMENTS
14.11 EUROFINS SCIENTIFIC
14.11.1 COMPANY SNAPSHOT
14.11.2 REVENUE ANALYSIS
14.11.3 PRODUCT PORTFOLIO
14.11.4 RECENT DEVELOPMENTS
14.12 GENEDX, LLC
14.12.1 COMPANY SNAPSHOT
14.12.2 PRODUCT PORTFOLIO
14.12.3 RECENT DEVELOPMENTS
14.13 GENEFIRST LIMITED.
14.13.1 COMPANY SNAPSHOT
14.13.2 PRODUCT PORTFOLIO
14.13.3 RECENT DEVELOPMENTS
14.14 ILLUMINA, INC
14.14.1 COMPANY SNAPSHOT
14.14.2 REVENUE ANALYSIS
14.14.3 PRODUCT PORTFOLIO
14.14.4 RECENT DEVELOPMENTS
14.15 INTEGRATED DNA TECHNOLOGIES, INC.
14.15.1 COMPANY SNAPSHOT
14.15.2 PRODUCT PORTFOLIO
14.15.3 RECENT DEVELOPMENTS
14.16 MERIDIAN BIOSCIENCE, INC.
14.16.1 COMPANY SNAPSHOT
14.16.2 REVENUE ANALYSIS
14.16.3 PRODUCT PORTFOLIO
14.16.4 RECENT DEVELOPMENTS
14.17 PSOMAGEN
14.17.1 COMPANY SNAPSHOT
14.17.2 REVENUE ANALYSIS
14.17.3 PRODUCT PORTFOLIO
14.17.4 RECENT DEVELOPMENTS
14.18 QIAGEN
14.18.1 COMPANY SNAPSHOT
14.18.2 REVENUE ANALYSIS
14.18.3 PRODUCT PORTFOLIO
14.18.4 RECENT DEVELOPMENTS
14.19 SOPHIA GENETICS
14.19.1 COMPANY SNAPSHOT
14.19.2 REVENUE ANALYSIS
14.19.3 PRODUCT PORTFOLIO
14.19.4 RECENT DEVELOPMENTS
14.2 TWIST BIOSCIENCE
14.20.1 COMPANY SNAPSHOT
14.20.2 REVENUE ANALYSIS
14.20.3 PRODUCT PORTFOLIO
14.20.4 RECENT DEVELOPMENTS
15 QUESTIONNAIRE
16 RELATED REPORTS
List of Table
TABLE 1 GLOBAL WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 2 GLOBAL SECOND-GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 3 GLOBAL SECOND-GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 4 GLOBAL THIRD-GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 5 GLOBAL WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 6 GLOBAL SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 7 GLOBAL SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 8 GLOBAL HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 9 GLOBAL ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 10 GLOBAL KITS IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 11 GLOBAL KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 12 GLOBAL SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 13 GLOBAL SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 14 GLOBAL WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 15 GLOBAL DRUG DISCOVERY AND DEVELOPMENT IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 16 GLOBAL AGRICULTURE & ANIMAL RESEARCH IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 17 GLOBAL DIAGNOSTICS IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 18 GLOBAL PERSONALIZED MEDICINE IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 19 GLOBAL OTHERS IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 20 GLOBAL WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 21 GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 22 GLOBAL ACADEMIC & RESEARCH INSTITUTES IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 23 GLOBAL HOSPITALS AND CLINICS IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 24 GLOBAL CLINICAL LABORATORIES IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 25 GLOBAL OTHERS IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 26 GLOBAL WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 27 GLOBAL DIRECT TRADE IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 28 GLOBAL RETAIL SALES IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 29 GLOBAL OTHERS IN WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 30 GLOBAL WHOLE EXOME SEQUENCING MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 31 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 32 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 33 NORTH AMERICA SECOND-GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 34 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 35 NORTH AMERICA SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 36 NORTH AMERICA HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 37 NORTH AMERICA ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 38 NORTH AMERICA KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 39 NORTH AMERICA SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 40 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 41 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 42 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 43 U.S. WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 44 U.S. SECOND-GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 45 U.S. WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 46 U.S. SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 47 U.S. HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 48 U.S. ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 49 U.S. KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 50 U.S. SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 51 U.S. WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 52 U.S. WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 53 U.S. WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 54 CANADA WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 55 CANADA SECOND-GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 56 CANADA WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 57 CANADA SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 58 CANADA HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 59 CANADA ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 60 CANADA KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 61 CANADA SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 62 CANADA WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 63 CANADA WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 64 CANADA WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 65 MEXICO WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 66 MEXICO SECOND-GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 67 MEXICO WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 68 MEXICO SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 69 MEXICO HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 70 MEXICO ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 71 MEXICO KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 72 MEXICO SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 73 MEXICO WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 74 MEXICO WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 75 MEXICO WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 76 EUROPE WHOLE EXOME SEQUENCING MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 77 EUROPE WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 78 EUROPE SECOND GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 79 EUROPE WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 80 EUROPE SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 81 EUROPE HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 82 EUROPE ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 83 EUROPE KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 84 EUROPE SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 85 EUROPE WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 86 EUROPE WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 87 EUROPE WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 88 GERMANY WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 89 GERMANY SECOND GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 90 GERMANY WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 91 GERMANY SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 92 GERMANY HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 93 GERMANY ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 94 GERMANY KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 95 GERMANY SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 96 GERMANY WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 97 GERMANY WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 98 GERMANY WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 99 FRANCE WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 100 FRANCE SECOND GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 101 FRANCE WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 102 FRANCE SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 103 FRANCE HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 104 FRANCE ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 105 FRANCE KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 106 FRANCE SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 107 FRANCE WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 108 FRANCE WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 109 FRANCE WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 110 U.K. WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 111 U.K. SECOND GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 112 U.K. WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 113 U.K. SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 114 U.K. HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 115 U.K. ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 116 U.K. KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 117 U.K. SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 118 U.K. WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 119 U.K. WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 120 U.K. WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 121 RUSSIA WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 122 RUSSIA SECOND GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 123 RUSSIA WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 124 RUSSIA SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 125 RUSSIA HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 126 RUSSIA ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 127 RUSSIA KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 128 RUSSIA SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 129 RUSSIA WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 130 RUSSIA WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 131 RUSSIA WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 132 ITALY WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 133 ITALY SECOND GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 134 ITALY WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 135 ITALY SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 136 ITALY HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 137 ITALY ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 138 ITALY KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 139 ITALY SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 140 ITALY WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 141 ITALY WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 142 ITALY WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 143 SPAIN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 144 SPAIN SECOND GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 145 SPAIN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 146 SPAIN SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 147 SPAIN HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 148 SPAIN ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 149 SPAIN KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 150 SPAIN SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 151 SPAIN WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 152 SPAIN WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 153 SPAIN WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 154 TURKEY WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 155 TURKEY SECOND GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 156 TURKEY WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 157 TURKEY SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 158 TURKEY HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 159 TURKEY ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 160 TURKEY KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 161 TURKEY SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 162 TURKEY WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 163 TURKEY WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 164 TURKEY WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 165 NETHERLANDS WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 166 NETHERLANDS SECOND GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 167 NETHERLANDS WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 168 NETHERLANDS SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 169 NETHERLANDS HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 170 NETHERLANDS ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 171 NETHERLANDS KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 172 NETHERLANDS SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 173 NETHERLANDS WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 174 NETHERLANDS WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 175 NETHERLANDS WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 176 SWITZERLAND WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 177 SWITZERLAND SECOND GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 178 SWITZERLAND WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 179 SWITZERLAND SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 180 SWITZERLAND HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 181 SWITZERLAND ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 182 SWITZERLAND KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 183 SWITZERLAND SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 184 SWITZERLAND WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 185 SWITZERLAND WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 186 SWITZERLAND WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 187 BELGIUM WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 188 BELGIUM SECOND GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 189 BELGIUM WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 190 BELGIUM SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 191 BELGIUM HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 192 BELGIUM ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 193 BELGIUM KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 194 BELGIUM SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 195 BELGIUM WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 196 BELGIUM WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 197 BELGIUM WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 198 REST OF EUROPE WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 199 ASIA-PACIFIC WHOLE EXOME SEQUENCING MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 200 ASIA-PACIFIC WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 201 ASIA-PACIFIC SECOND GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 202 ASIA-PACIFIC WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 203 ASIA-PACIFIC SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 204 ASIA-PACIFIC HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 205 ASIA-PACIFIC ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 206 ASIA-PACIFIC KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 207 ASIA-PACIFIC SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 208 ASIA-PACIFIC WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 209 ASIA-PACIFIC WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 210 ASIA-PACIFIC WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 211 CHINA WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 212 CHINA SECOND GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 213 CHINA WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 214 CHINA SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 215 CHINA HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 216 CHINA ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 217 CHINA KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 218 CHINA SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 219 CHINA WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 220 CHINA WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 221 CHINA WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 222 JAPAN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 223 JAPAN SECOND GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 224 JAPAN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 225 JAPAN SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 226 JAPAN HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 227 JAPAN ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 228 JAPAN KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 229 JAPAN SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 230 JAPAN WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 231 JAPAN WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 232 JAPAN WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 233 INDIA WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 234 INDIA SECOND GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 235 INDIA WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 236 INDIA SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 237 INDIA HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 238 INDIA ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 239 INDIA KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 240 INDIA SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 241 INDIA WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 242 INDIA WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 243 INDIA WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 244 SOUTH KOREA WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 245 SOUTH KOREA SECOND GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 246 SOUTH KOREA WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 247 SOUTH KOREA SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 248 SOUTH KOREA HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 249 SOUTH KOREA ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 250 SOUTH KOREA KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 251 SOUTH KOREA SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 252 SOUTH KOREA WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 253 SOUTH KOREA WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 254 SOUTH KOREA WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 255 AUSTRALIA WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 256 AUSTRALIA SECOND GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 257 AUSTRALIA WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 258 AUSTRALIA SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 259 AUSTRALIA HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 260 AUSTRALIA ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 261 AUSTRALIA KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 262 AUSTRALIA SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 263 AUSTRALIA WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 264 AUSTRALIA WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 265 AUSTRALIA WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 266 SINGAPORE WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 267 SINGAPORE SECOND GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 268 SINGAPORE WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 269 SINGAPORE SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 270 SINGAPORE HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 271 SINGAPORE ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 272 SINGAPORE KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 273 SINGAPORE SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 274 SINGAPORE WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 275 SINGAPORE WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 276 SINGAPORE WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 277 THAILAND WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 278 THAILAND SECOND GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 279 THAILAND WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 280 THAILAND SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 281 THAILAND HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 282 THAILAND ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 283 THAILAND KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 284 THAILAND SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 285 THAILAND WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 286 THAILAND WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 287 THAILAND WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 288 INDONESIA WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 289 INDONESIA SECOND GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 290 INDONESIA WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 291 INDONESIA SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 292 INDONESIA HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 293 INDONESIA ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 294 INDONESIA KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 295 INDONESIA SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 296 INDONESIA WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 297 INDONESIA WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 298 INDONESIA WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 299 PHILIPPINES WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 300 PHILIPPINES SECOND GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 301 PHILIPPINES WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 302 PHILIPPINES SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 303 PHILIPPINES HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 304 PHILIPPINES ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 305 PHILIPPINES KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 306 PHILIPPINES SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 307 PHILIPPINES WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 308 PHILIPPINES WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 309 PHILIPPINES WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 310 MALAYSIA WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 311 MALAYSIA SECOND GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 312 MALAYSIA WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 313 MALAYSIA SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 314 MALAYSIA HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 315 MALAYSIA ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 316 MALAYSIA KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 317 MALAYSIA SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 318 MALAYSIA WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 319 MALAYSIA WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 320 MALAYSIA WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 321 VIETNAM WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 322 VIETNAM SECOND GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 323 VIETNAM WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 324 VIETNAM SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 325 VIETNAM HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 326 VIETNAM ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 327 VIETNAM KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 328 VIETNAM SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 329 VIETNAM WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 330 VIETNAM WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 331 VIETNAM WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 332 REST OF ASIA-PACIFIC WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 333 SOUTH AMERICA WHOLE EXOME SEQUENCING MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 334 SOUTH AMERICA WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 335 SOUTH AMERICA SECOND-GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 336 SOUTH AMERICA WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 337 SOUTH AMERICA SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 338 SOUTH AMERICA HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 339 SOUTH AMERICA ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 340 SOUTH AMERICA KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 341 SOUTH AMERICA SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 342 SOUTH AMERICA WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 343 SOUTH AMERICA WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 344 SOUTH AMERICA WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 345 BRAZIL WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 346 BRAZIL SECOND-GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 347 BRAZIL WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 348 BRAZIL SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 349 BRAZIL HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 350 BRAZIL ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 351 BRAZIL KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 352 BRAZIL SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 353 BRAZIL WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 354 BRAZIL WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 355 BRAZIL WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 356 ARGENTINA WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 357 ARGENTINA SECOND-GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 358 ARGENTINA WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 359 ARGENTINA SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 360 ARGENTINA HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 361 ARGENTINA ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 362 ARGENTINA KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 363 ARGENTINA SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 364 ARGENTINA WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 365 ARGENTINA WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 366 ARGENTINA WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 367 REST OF SOUTH AMERICA WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 368 MIDDLE EAST AND AFRICA WHOLE EXOME SEQUENCING MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 369 MIDDLE EAST AND AFRICA WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 370 MIDDLE EAST AND AFRICA SECOND-GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 371 MIDDLE EAST AND AFRICA WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 372 MIDDLE EAST AND AFRICA SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 373 MIDDLE EAST AND AFRICA HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 374 MIDDLE EAST AND AFRICA ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 375 MIDDLE EAST AND AFRICA KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 376 MIDDLE EAST AND AFRICA SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 377 MIDDLE EAST AND AFRICA WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 378 MIDDLE EAST AND AFRICA WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 379 MIDDLE EAST AND AFRICA WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 380 SOUTH AFRICA WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 381 SOUTH AFRICA SECOND-GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 382 SOUTH AFRICA WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 383 SOUTH AFRICA SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 384 SOUTH AFRICA HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 385 SOUTH AFRICA ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 386 SOUTH AFRICA KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 387 SOUTH AFRICA SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 388 SOUTH AFRICA WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 389 SOUTH AFRICA WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 390 SOUTH AFRICA WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 391 SAUDI ARABIA WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 392 SAUDI ARABIA SECOND-GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 393 SAUDI ARABIA WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 394 SAUDI ARABIA SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 395 SAUDI ARABIA HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 396 SAUDI ARABIA ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 397 SAUDI ARABIA KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 398 SAUDI ARABIA SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 399 SAUDI ARABIA WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 400 SAUDI ARABIA WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 401 SAUDI ARABIA WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 402 U.A.E WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 403 U.A.E SECOND-GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 404 U.A.E WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 405 U.A.E SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 406 U.A.E HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 407 U.A.E ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 408 U.A.E KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 409 U.A.E SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 410 U.A.E WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 411 U.A.E WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 412 U.A.E WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 413 ISRAEL WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 414 ISRAEL SECOND-GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 415 ISRAEL WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 416 ISRAEL SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 417 ISRAEL HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 418 ISRAEL ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 419 ISRAEL KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 420 ISRAEL SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 421 ISRAEL WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 422 ISRAEL WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 423 ISRAEL WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 424 EGYPT WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 425 EGYPT SECOND-GENERATION SEQUENCING IN WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
TABLE 426 EGYPT WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 427 EGYPT SYSTEMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 428 EGYPT HISEQ SERIES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 429 EGYPT ION TORRENT PLATFORMS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 430 EGYPT KITS IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 431 EGYPT SERVICES IN WHOLE EXOME SEQUENCING MARKET, BY PRODUCT AND SERVICE, 2020-2029 (USD MILLION)
TABLE 432 EGYPT WHOLE EXOME SEQUENCING MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 433 EGYPT WHOLE EXOME SEQUENCING MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 434 EGYPT WHOLE EXOME SEQUENCING MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 435 REST OF MIDDLE EAST AND AFRICA WHOLE EXOME SEQUENCING MARKET, BY COMPONENT, 2020-2029 (USD MILLION)
List of Figure
FIGURE 1 GLOBAL WHOLE EXOME SEQUENCING (WES) MARKET: SEGMENTATION
FIGURE 2 GLOBAL WHOLE EXOME SEQUENCING (WES) MARKET: DATA TRIANGULATION
FIGURE 3 GLOBAL WHOLE EXOME SEQUENCING (WES) MARKET: DROC ANALYSIS
FIGURE 4 GLOBAL WHOLE EXOME SEQUENCING (WES) MARKET: REGIONAL VS COUNTRY MARKET ANALYSIS
FIGURE 5 GLOBAL WHOLE EXOME SEQUENCING (WES) MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 GLOBAL WHOLE EXOME SEQUENCING (WES) MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 GLOBAL WHOLE EXOME SEQUENCING (WES) MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 8 GLOBAL WHOLE EXOME SEQUENCING (WES) MARKET: DBMR MARKET POSITION GRID
FIGURE 9 GLOBAL WHOLE EXOME SEQUENCING (WES) MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 GLOBAL WHOLE EXOME SEQUENCING (WES) MARKET: SEGMENTATION
FIGURE 11 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE GLOBAL WHOLE EXOME SEQUENCING (WES) MARKET AND ASIA-PACIFIC IS ESTIMATED TO BE GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 12 INCREASE IN USE OF WES TECHNOLOGY FOR NEW SCIENTIFIC APPLICATIONS AND INCREASING THE PREFERENCE OF WES OVER WHOLE-GENOME SEQUENCING IS ITS LOW-COST SEQUENCING CAPABILITY IS EXPECTED TO DRIVE THE GLOBAL WHOLE EXOME SEQUENCING (WES) MARKET IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 13 THE INSTRUMENT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL WHOLE EXOME SEQUENCING (WES) MARKET IN 2022 & 2029
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF THE GLOBAL WHOLE EXOME SEQUENCING MARKET
FIGURE 15 GLOBAL WHOLE EXOME SEQUENCING MARKET: BY COMPONENT, 2021
FIGURE 16 GLOBAL WHOLE EXOME SEQUENCING MARKET: BY COMPONENT, 2022-2029 (USD MILLION)
FIGURE 17 GLOBAL WHOLE EXOME SEQUENCING MARKET: BY COMPONENT, CAGR (2022-2029)
FIGURE 18 GLOBAL WHOLE EXOME SEQUENCING MARKET: BY COMPONENT, LIFELINE CURVE
FIGURE 19 GLOBAL WHOLE EXOME SEQUENCING MARKET: BY PRODUCT AND SERVICE, 2021
FIGURE 20 GLOBAL WHOLE EXOME SEQUENCING MARKET: BY PRODUCT AND SERVICE, 2022-2029 (USD MILLION)
FIGURE 21 GLOBAL WHOLE EXOME SEQUENCING MARKET: BY PRODUCT AND SERVICE, CAGR (2022-2029)
FIGURE 22 GLOBAL WHOLE EXOME SEQUENCING MARKET: BY PRODUCT AND SERVICE, LIFELINE CURVE
FIGURE 23 GLOBAL WHOLE EXOME SEQUENCING MARKET: BY APPLICATION, 2021
FIGURE 24 LOBAL WHOLE EXOME SEQUENCING MARKET: BY APPLICATION, 2022-2029 (USD MILLION)
FIGURE 25 GLOBAL WHOLE EXOME SEQUENCING MARKET: BY APPLICATION, CAGR (2022-2029)
FIGURE 26 GLOBAL WHOLE EXOME SEQUENCING MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 27 GLOBAL WHOLE EXOME SEQUENCING MARKET: BY END USER, 2021
FIGURE 28 GLOBAL WHOLE EXOME SEQUENCING MARKET: BY END USER, 2022-2029 (USD MILLION)
FIGURE 29 GLOBAL WHOLE EXOME SEQUENCING MARKET: BY END USER, CAGR (2022-2029)
FIGURE 30 GLOBAL WHOLE EXOME SEQUENCING MARKET: BY END USER, LIFELINE CURVE
FIGURE 31 GLOBAL WHOLE EXOME SEQUENCING MARKET: BY DISTRIBUTION CHANNEL, 2021
FIGURE 32 GLOBAL WHOLE EXOME SEQUENCING MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
FIGURE 33 GLOBAL WHOLE EXOME SEQUENCING MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)
FIGURE 34 GLOBAL WHOLE EXOME SEQUENCING MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 35 GLOBAL WHOLE EXOME SEQUENCING MARKET: SNAPSHOT (2021)
FIGURE 36 GLOBAL WHOLE EXOME SEQUENCING MARKET: BY COUNTRY (2021)
FIGURE 37 GLOBAL WHOLE EXOME SEQUENCING MARKET: BY COUNTRY (2022 & 2029)
FIGURE 38 GLOBAL WHOLE EXOME SEQUENCING MARKET: BY COUNTRY (2021 & 2029)
FIGURE 39 GLOBAL WHOLE EXOME SEQUENCING MARKET: BY COMPONENT (2022-2029)
FIGURE 40 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: SNAPSHOT (2021)
FIGURE 41 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY COUNTRY (2021)
FIGURE 42 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY COUNTRY (2022 & 2029)
FIGURE 43 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY COUNTRY (2021 & 2029)
FIGURE 44 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY COMPONENT (2022-2029)
FIGURE 45 EUROPE WHOLE EXOME SEQUENCING MARKET: SNAPSHOT (2021)
FIGURE 46 EUROPE WHOLE EXOME SEQUENCING MARKET: BY COUNTRY (2021)
FIGURE 47 EUROPE WHOLE EXOME SEQUENCING MARKET: BY COUNTRY (2022 & 2029)
FIGURE 48 EUROPE WHOLE EXOME SEQUENCING MARKET: BY COUNTRY (2021 & 2029)
FIGURE 49 EUROPE WHOLE EXOME SEQUENCING MARKET: BY COMPONENT (2022-2029)
FIGURE 50 ASIA-PACIFIC WHOLE EXOME SEQUENCING MARKET: SNAPSHOT (2021)
FIGURE 51 ASIA-PACIFIC WHOLE EXOME SEQUENCING MARKET: BY COUNTRY (2021)
FIGURE 52 ASIA-PACIFIC WHOLE EXOME SEQUENCING MARKET: BY COUNTRY (2022 & 2029)
FIGURE 53 ASIA-PACIFIC WHOLE EXOME SEQUENCING MARKET: BY COUNTRY (2021 & 2029)
FIGURE 54 ASIA-PACIFIC WHOLE EXOME SEQUENCING MARKET: BY COMPONENT (2022-2029)
FIGURE 55 SOUTH AMERICA WHOLE EXOME SEQUENCING MARKET: SNAPSHOT (2021)
FIGURE 56 SOUTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY COUNTRY (2021)
FIGURE 57 SOUTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY COUNTRY (2022 & 2029)
FIGURE 58 SOUTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY COUNTRY (2021 & 2029)
FIGURE 59 SOUTH AMERICA WHOLE EXOME SEQUENCING MARKET: BY COMPONENT (2022-2029)
FIGURE 60 MIDDLE EAST AND AFRICA WHOLE EXOME SEQUENCING MARKET: SNAPSHOT (2021)
FIGURE 61 MIDDLE EAST AND AFRICA WHOLE EXOME SEQUENCING MARKET: BY COUNTRY (2021)
FIGURE 62 MIDDLE EAST AND AFRICA WHOLE EXOME SEQUENCING MARKET: BY COUNTRY (2022 & 2029)
FIGURE 63 MIDDLE EAST AND AFRICA WHOLE EXOME SEQUENCING MARKET: BY COUNTRY (2021 & 2029)
FIGURE 64 MIDDLE EAST AND AFRICA WHOLE EXOME SEQUENCING MARKET: BY COMPONENT (2022-2029)
FIGURE 65 GLOBAL WHOLE EXOME SEQUENCING MARKET: COMPANY SHARE 2021 (%)
FIGURE 66 NORTH AMERICA WHOLE EXOME SEQUENCING MARKET: COMPANY SHARE 2021 (%)
FIGURE 67 EUROPE WHOLE EXOME SEQUENCING MARKET: COMPANY SHARE 2021 (%)
FIGURE 68 ASIA-PACIFIC WHOLE EXOME SEQUENCING MARKET: COMPANY SHARE 2021 (%)
منهجية البحث
يتم جمع البيانات وتحليل سنة الأساس باستخدام وحدات جمع البيانات ذات أحجام العينات الكبيرة. تتضمن المرحلة الحصول على معلومات السوق أو البيانات ذات الصلة من خلال مصادر واستراتيجيات مختلفة. تتضمن فحص وتخطيط جميع البيانات المكتسبة من الماضي مسبقًا. كما تتضمن فحص التناقضات في المعلومات التي شوهدت عبر مصادر المعلومات المختلفة. يتم تحليل بيانات السوق وتقديرها باستخدام نماذج إحصائية ومتماسكة للسوق. كما أن تحليل حصة السوق وتحليل الاتجاهات الرئيسية هي عوامل النجاح الرئيسية في تقرير السوق. لمعرفة المزيد، يرجى طلب مكالمة محلل أو إرسال استفسارك.
منهجية البحث الرئيسية التي يستخدمها فريق بحث DBMR هي التثليث البيانات والتي تتضمن استخراج البيانات وتحليل تأثير متغيرات البيانات على السوق والتحقق الأولي (من قبل خبراء الصناعة). تتضمن نماذج البيانات شبكة تحديد موقف البائعين، وتحليل خط زمني للسوق، ونظرة عامة على السوق ودليل، وشبكة تحديد موقف الشركة، وتحليل براءات الاختراع، وتحليل التسعير، وتحليل حصة الشركة في السوق، ومعايير القياس، وتحليل حصة البائعين على المستوى العالمي مقابل الإقليمي. لمعرفة المزيد عن منهجية البحث، أرسل استفسارًا للتحدث إلى خبراء الصناعة لدينا.
التخصيص متاح
تعد Data Bridge Market Research رائدة في مجال البحوث التكوينية المتقدمة. ونحن نفخر بخدمة عملائنا الحاليين والجدد بالبيانات والتحليلات التي تتطابق مع هدفهم. ويمكن تخصيص التقرير ليشمل تحليل اتجاه الأسعار للعلامات التجارية المستهدفة وفهم السوق في بلدان إضافية (اطلب قائمة البلدان)، وبيانات نتائج التجارب السريرية، ومراجعة الأدبيات، وتحليل السوق المجدد وقاعدة المنتج. ويمكن تحليل تحليل السوق للمنافسين المستهدفين من التحليل القائم على التكنولوجيا إلى استراتيجيات محفظة السوق. ويمكننا إضافة عدد كبير من المنافسين الذين تحتاج إلى بيانات عنهم بالتنسيق وأسلوب البيانات الذي تبحث عنه. ويمكن لفريق المحللين لدينا أيضًا تزويدك بالبيانات في ملفات Excel الخام أو جداول البيانات المحورية (كتاب الحقائق) أو مساعدتك في إنشاء عروض تقديمية من مجموعات البيانات المتوفرة في التقرير.
